Converging technologies in the clinical trials space are improving efficiencies on most fronts of the clinical research process. Gaps remain, however, and if we as an industry are to drive further efficiencies in clinical development, we must rethink our processes and our technology in a more modern context. Through direct work with a focus group composed of representatives from many divisions of the industry, the product development team at Datatrak reached the conclusion that regulatory submission, among other operations of in

Join for free to read